Biologic Drugs With Mechanism of Action: Interleukin 4 Receptor alpha Antagonists
✉ Email this page to a colleague
Biologic Drugs With Mechanism of Action: Interleukin 4 Receptor alpha Antagonists
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals, Inc. | DUPIXENT | dupilumab | Injection | 761055 | 2017-03-28 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |